Letter 2: Intraoperative diagnosis and treatment of parathyroid cancer and atypical parathyroid adenoma (Br J Surg 2007; 94: 566–570)
暂无分享,去创建一个
A. Gill | S. Sidhu | L. Delbridge | M. Sywak | G. Meyer-Rochow | R. Alvarado | A. Gill | G. Y. Meyer‐Rochow
[1] A. Gill,et al. Loss of Nuclear Expression of Parafibromin Distinguishes Parathyroid Carcinomas and Hyperparathyroidism-Jaw Tumor (HPT-JT) Syndrome-related Adenomas From Sporadic Parathyroid Adenomas and Hyperplasias , 2006, The American journal of surgical pathology.
[2] R. DeLellis. Parathyroid Carcinoma: An Overview , 2005, Advances in anatomic pathology.
[3] C. Harmer,et al. One stage treatment of parathyroid cancer. , 2005, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[4] Jeffrey E. Lee,et al. Parathyroid carcinoma: A 22‐year experience , 2004, Head & neck.
[5] J. Carpten,et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. , 2003, The New England journal of medicine.
[6] K. Chihara,et al. Trial to predict malignancy of affected parathyroid glands in primary hyperparathyroidism. , 2003, Endocrine journal.
[7] J. Carpten,et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism–jaw tumor syndrome , 2002, Nature Genetics.
[8] A. Piotto,et al. [Parathyroid carcinoma. Therapeutic strategies derived from 20 years of experience]. , 2001, Minerva endocrinologica.
[9] F. Menestrina,et al. A rapid immunostaining method for frozen sections. , 1994, Biotechnic & histochemistry : official publication of the Biological Stain Commission.